PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35572689-0 2022 Emergence of a Hypervirulent Tigecycline-Resistant Klebsiella pneumoniae Strain Co-producing bla NDM-1 and bla KPC-2 With an Uncommon Sequence Type ST464 in Southwestern China. Tigecycline 29-40 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 111-116 22016687-5 2011 The KPC-2-producing isolate was resistant to all tested beta-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. Tigecycline 253-264 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 4-9 35038616-0 2022 Evolution of tet(A) Variant Mediating Tigecycline Resistance in KPC-2-Producing Klebsiella pneumoniae during Tigecycline Treatment. Tigecycline 38-49 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 64-69 35038616-0 2022 Evolution of tet(A) Variant Mediating Tigecycline Resistance in KPC-2-Producing Klebsiella pneumoniae during Tigecycline Treatment. Tigecycline 109-120 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 64-69 29101083-0 2017 Draft genome sequence of a tigecycline-resistant KPC-2-producing Klebsiella pneumoniae ST15 clinical isolate from China. Tigecycline 27-38 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 49-54 29101083-3 2017 Here we report the draft genome sequence of a clinical tigecycline-resistant KPC-2-producing K. pneumoniae isolate (TRKP1). Tigecycline 55-66 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 77-82 25801560-0 2015 In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials. Tigecycline 62-73 carbapenem-hydrolyzing beta-lactamase KPC-2 Klebsiella pneumoniae 82-87